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therosclerotic lesion progression and the formation of
uminal thrombosis superimposed on a ruptured or eroded
ulnerable plaque is well recognized as the pathological
ause of the majority of cardiovascular events, such as stroke
nd myocardial infarction. The artery is not a rigid tube
ecause it is capable of adapting to plaque growth by
xpansive remodeling (1). The increase in arterial diameter
s a natural adaptation in response to lesion growth so that
uminal blood flow remains preserved. However, it has been
hown that arteries may also undergo constrictive remodel-
ng, which accelerates luminal narrowing by plaque growth
2). Both types of geometrical remodeling may be observed
n 1 individual in the same arterial segment. Arterial
eometrical remodeling is a double edged sword because
xpansively remodeled plaques harbor inflammatory and
rotease activity beneath the surface of the lumen. Expan-
ion of vessel diameter in response to progression of
therosclerotic disease is associated with the presence of an
nflammatory lipid-rich plaque phenotype that is more likely
o give rise to acute coronary syndromes, whereas constric-
ive remodeling is associated with a more fibrous stable
laque phenotype (2–4).
See page 1708
Many researchers have focused on the clinical and bio-
ogical relevance of the variation in remodeling responses
nd used in vivo intravascular ultrasound and post-mortem–
btained arterial specimens for this purpose.
In this issue of the Journal, Miao et al. (5) report the use
f coronary wall magnetic resonance imaging (MRI) to
tudy coronary vessel wall remodeling in asymptomatic
atients. The investigators suggest that coronary wall MRI
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merican College of Cardiology.c
From the Laboratory of Experimental Cardiology, University Medical Centre
trecht, Utrecht, the Netherlands.s more likely applicable as a screening method for studying
essel wall characteristics compared with intravascular ultra-
ound because of its noninvasive nature. In 179 asymptom-
tic patients, they studied the coronary vessel size in relation
o coronary wall thickness. This study confirms the earlier
ost-mortem observations by Glagov et al. (1); for example,
orrelating plaque area and vessel area measurements from
ultiple individuals showed that on average, expansive
emodeling fully compensated the plaque growth, thereby
reventing luminal narrowing. Even more, the increase in
laque area was associated with a concomitant increase in
umen area because of overcompensation. This study is of
nterest because the presence of expansive remodeling is
hown in vivo in asymptomatic patients using a noninvasive
maging tool.
After 2 decades with numerous research studies that
xplored the phenomenon of de novo atherosclerotic re-
odeling, the question remains: what is the clinical rele-
ance of in vivo visualization of the degree and mode of
eometrical atherosclerotic remodeling? Does the direction
f a remodeling response have a prognostic value, or can it
erve as a surrogate measure of progression of disease or
acilitate the testing of therapeutic efficacy of newly devel-
ped drugs?
The development and testing of drugs that aim to
tabilize vulnerable plaques to prevent acute manifestations
f atherosclerotic disease is a major challenge. Atheroscle-
otic lesion formation is slowly progressing, and large
atient numbers are required for pharmacological hard end
oint studies to reach sufficient power. Currently there are
o surrogate measures for plaque stabilization that are
ccepted as end points in pharmaceutical studies. Next to
he use of coronary angiography, changes in carotid intima-
edia thickness using duplex ultrasound and plaque cross-
ectional area assessed with intravascular ultrasound are the
ost appreciated surrogate end points in clinical trials of
ovel atherosclerotic disease therapies alongside ongoing
linical end point trials (6).
The ultrasound techniques have an advantage over the
raditional method of coronary angiography for imaging
therosclerosis in that they allow direct visualization of
therosclerotic plaques in situ. The search for additional
urrogate imaging markers for progression of atherosclerotic
isease is ongoing and is explored in longitudinal studies
7). As mentioned earlier, the variation in arterial diameter,
or example, geometrical remodeling, is a widely appreciated
eometrical measure in ultrasound research. The association
etween variability in vessel size and histological features of
he vulnerable plaque makes geometrical atherosclerotic
emodeling a potential ultrasound measure that could serve
s a surrogate for drug efficacy. Indeed, Schoenhagen et al.
8) showed in a subgroup of the REVERSAL (Reversal of
therosclerosis With Aggressive Lipid-Lowering Therapy)
rial that constrictive remodeling of the arterial wall oc-
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ith acute coronary syndromes, the presence of expansively
emodeled lesions before stenting was predictive for the
ccurrence of cardiac events and lesion revascularization at 2
ears (9). On the other hand, however, in the same
forementioned substudy of the REVERSAL trial it was
lso shown that the mode of arterial remodeling (expansive
r constrictive) was not related to a change in atheroma
olume comparing serial ultrasound data at baseline and
ollow-up (10), suggesting that the mode of geometrical
emodeling cannot serve as an alternative surrogate measure
or plaque progression over time. To summarize, hard
vidence that the direction and extent of arterial remodeling
as prognostic value for the occurrence of adverse cardio-
ascular events is lacking. Solid scientific arguments for
creening of patients for the absence or presence of expan-
ively remodeled plaques are yet to be provided.
Imaging studies that attempt to assess the degree and
irection of atherosclerotic remodeling are hampered by a
ethodological limitation that is difficult to overcome. How
an one accurately and reproducibly assess a degree of
therosclerotic remodeling? Pathological studies (1) and the
RI study by Miao et al. (5) correlated plaque and vessel
reas by pooling data from single-vessel segments. This
pproach requires correction for many factors that could
nfluence local vessel size, such as sex, age, length, level of
xercise training, anatomical localization, and so on. This
ross-sectional approach may suggest a positive correlation
etween plaque, lumen, and vessel size but will not provide
remodeling measure for a specific individual. Another
pproach has been widely applied by researchers who
ystematically examined multiple histological sections or
ltrasound images in arterial segments. Subsequently, a site
hat appeared least affected by the atherosclerotic disease
as used as a reference that allowed the calculation of a
emodeling index for a lesion of interest. However, this is
lso a cross-sectional method suffering from the limitation
hat the reference site is likely to have undergone geomet-
ical remodeling as well. The remodeling response can also
e assessed by executing serial imaging studies. Indeed, it
as been shown that cross-sectional and serial assessments
f arterial remodeling are discordant (11). This was found to
e caused by concomitant remodeling of the reference sites.
owever, thus far only limited patient numbers have been
tudied to assess arterial remodeling in a longitudinal study.
The current concepts describing the natural history of
therosclerosis and subsequent arterial remodeling are
ainly based on cross-sectional pathological observations
nd studies in genetically modified animals. Longitudinal
tudies on the progression of atherosclerotic disease in
umans are still in their infancy and mainly address the Kdvanced stages of the disease (7). Imaging studies that
epict the grade and direction of de novo atherosclerotic
emodeling may help to understand the natural progression
f the disease. However, longitudinal studies will need to
eveal that the extent and direction of atherosclerotic re-
odeling has prognostic relevance or that it may serve as a
urrogate for disease progression. Until then, geometrical
emodeling will remain in the clinical experimental research
rena.
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